• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢重编程相关基因预测直肠癌的总生存期。

Metabolic reprogramming-associated genes predict overall survival for rectal cancer.

机构信息

Departments of Oncological Surgery, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.

出版信息

J Cell Mol Med. 2020 May;24(10):5842-5849. doi: 10.1111/jcmm.15254. Epub 2020 Apr 13.

DOI:10.1111/jcmm.15254
PMID:32285560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7214181/
Abstract

Metabolic reprogramming has become a hot topic recently in the regulation of tumour biology. Although hundreds of altered metabolic genes have been reported to be associated with tumour development and progression, the important prognostic role of these metabolic genes remains unknown. We downloaded messenger RNA expression profiles and clinicopathological data from The Cancer Genome Atlas and the Gene Expression Omnibus database to uncover the prognostic role of these metabolic genes. Univariate Cox regression analysis and lasso Cox regression model were utilized in this study to screen prognostic associated metabolic genes. Patients with high-risk demonstrated significantly poorer survival outcomes than patients with low-risk in the TCGA database. Also, patients with high-risk still showed significantly poorer survival outcomes than patients with low-risk in the GEO database. What is more, gene set enrichment analyses were performed in this study to uncover significantly enriched GO terms and pathways in order to help identify potential underlying mechanisms. Our study identified some survival-related metabolic genes for rectal cancer prognosis prediction. These genes might play essential roles in the regulation of metabolic microenvironment and in providing significant potential biomarkers in metabolic treatment.

摘要

代谢重编程已成为肿瘤生物学调控领域的一个热门话题。尽管已有数百种代谢基因的改变与肿瘤的发生和发展相关,但这些代谢基因的重要预后作用仍不清楚。我们从癌症基因组图谱和基因表达综合数据库下载了信使 RNA 表达谱和临床病理数据,以揭示这些代谢基因的预后作用。本研究采用单因素 Cox 回归分析和套索 Cox 回归模型筛选预后相关的代谢基因。在 TCGA 数据库中,高风险组患者的生存结局明显差于低风险组患者。此外,在 GEO 数据库中,高风险组患者的生存结局仍明显差于低风险组患者。更重要的是,本研究进行了基因集富集分析,以揭示显著富集的 GO 术语和途径,以帮助确定潜在的潜在机制。我们的研究鉴定了一些与直肠癌预后相关的代谢基因,这些基因可能在代谢微环境的调控中发挥重要作用,并为代谢治疗提供有意义的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/4cd2471af251/JCMM-24-5842-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/3f254a2d0f12/JCMM-24-5842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/311322e7088b/JCMM-24-5842-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/df099c618155/JCMM-24-5842-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/8cee0dd63388/JCMM-24-5842-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/bbf7845991a0/JCMM-24-5842-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/4cd2471af251/JCMM-24-5842-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/3f254a2d0f12/JCMM-24-5842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/311322e7088b/JCMM-24-5842-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/df099c618155/JCMM-24-5842-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/8cee0dd63388/JCMM-24-5842-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/bbf7845991a0/JCMM-24-5842-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/7214181/4cd2471af251/JCMM-24-5842-g006.jpg

相似文献

1
Metabolic reprogramming-associated genes predict overall survival for rectal cancer.代谢重编程相关基因预测直肠癌的总生存期。
J Cell Mol Med. 2020 May;24(10):5842-5849. doi: 10.1111/jcmm.15254. Epub 2020 Apr 13.
2
Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma.代谢重编程相关基因在肝细胞癌患者中的预后作用。
Aging (Albany NY). 2020 Nov 12;12(21):22199-22219. doi: 10.18632/aging.104122.
3
A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer.一种用于预测结肠癌预后的新型十七基因代谢标志物。
Biomed Res Int. 2020 Nov 17;2020:4845360. doi: 10.1155/2020/4845360. eCollection 2020.
4
A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.一项通过机器学习策略确定肺腺癌新预后预测模型的大型队列研究。
BMC Cancer. 2019 Sep 5;19(1):886. doi: 10.1186/s12885-019-6101-7.
5
Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.基于RNA测序的8长非编码RNA特征预测食管癌生存情况的鉴定
Med Sci Monit. 2016 Dec 28;22:5163-5172. doi: 10.12659/msm.902615.
6
Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.通过综合生物信息学分析筛选结直肠癌的关键基因和信号通路。
Mol Med Rep. 2019 Aug;20(2):1259-1269. doi: 10.3892/mmr.2019.10336. Epub 2019 Jun 4.
7
A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.一个稳健的六基因预后签名,用于预测非小细胞肺癌的无病生存和总生存。
J Transl Med. 2019 May 14;17(1):152. doi: 10.1186/s12967-019-1899-y.
8
A four-gene-based prognostic model predicts overall survival in patients with hepatocellular carcinoma.基于四个基因的预后模型可预测肝细胞癌患者的总生存期。
J Cell Mol Med. 2018 Dec;22(12):5928-5938. doi: 10.1111/jcmm.13863. Epub 2018 Sep 24.
9
Identification of a four-gene metabolic signature predicting overall survival for hepatocellular carcinoma.鉴定出一种四基因代谢特征,可预测肝细胞癌的总生存期。
J Cell Physiol. 2020 Feb;235(2):1624-1636. doi: 10.1002/jcp.29081. Epub 2019 Jul 16.
10
Overexpression of LncRNA HOTAIR is Associated with Poor Prognosis in Thyroid Carcinoma: A Study Based on TCGA and GEO Data.长链非编码RNA HOTAIR的过表达与甲状腺癌的不良预后相关:一项基于TCGA和GEO数据的研究
Horm Metab Res. 2017 May;49(5):388-399. doi: 10.1055/s-0043-103346. Epub 2017 Mar 28.

引用本文的文献

1
Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with two step feature selection and ensemble learning.利用两步特征选择和集成学习预测局部晚期直肠癌新辅助放化疗的病理反应
Sci Rep. 2025 Mar 22;15(1):9936. doi: 10.1038/s41598-025-94337-y.
2
Targeting CDK1 and copper homeostasis in breast cancer via a nanopolymer drug delivery system.通过纳米聚合物药物递送系统靶向乳腺癌中的细胞周期蛋白依赖性激酶1(CDK1)和铜稳态。
Cell Biol Toxicol. 2024 Dec 26;41(1):16. doi: 10.1007/s10565-024-09958-2.
3
Human sulfotransferase physiological role and the impact of genetic polymorphism on enzyme activity and pathological conditions.

本文引用的文献

1
Can less be more? Organ preservation strategies in the management of rectal cancer.更少是否可以更多?直肠癌管理中的器官保存策略。
Curr Oncol. 2019 Nov;26(Suppl 1):S16-S23. doi: 10.3747/co.26.5841. Epub 2019 Nov 1.
2
Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.新辅助放化疗后局部进展期直肠癌的外科治疗。
Kaohsiung J Med Sci. 2020 Mar;36(3):152-159. doi: 10.1002/kjm2.12161. Epub 2019 Dec 9.
3
Restaging Patients with Rectal Cancer Following Neoadjuvant Chemoradiation: A Systematic Review.
人类磺基转移酶的生理作用以及基因多态性对酶活性和病理状况的影响。
Front Genet. 2024 Aug 30;15:1464243. doi: 10.3389/fgene.2024.1464243. eCollection 2024.
4
An immune-related gene prognostic prediction risk model for neoadjuvant chemoradiotherapy in rectal cancer using artificial intelligence.基于人工智能的直肠癌新辅助放化疗免疫相关基因预后预测风险模型
Front Oncol. 2024 Feb 9;14:1294440. doi: 10.3389/fonc.2024.1294440. eCollection 2024.
5
Metabolic genes, a potential predictor of prognosis and immunogenicity of clear cell renal cell carcinoma.代谢基因,透明细胞肾细胞癌预后和免疫原性的潜在预测指标。
Am J Cancer Res. 2023 Apr 15;13(4):1387-1406. eCollection 2023.
6
A prognostic 15-gene model based on differentially expressed genes among metabolic subtypes in diffuse large B-cell lymphoma.基于弥漫性大 B 细胞淋巴瘤代谢亚型中差异表达基因的预后 15 基因模型。
Pathol Oncol Res. 2023 Feb 2;29:1610819. doi: 10.3389/pore.2023.1610819. eCollection 2023.
7
Using Single-Cell RNA Sequencing and MicroRNA Targeting Data to Improve Colorectal Cancer Survival Prediction.利用单细胞 RNA 测序和 microRNA 靶向数据提高结直肠癌生存预测。
Cells. 2023 Jan 5;12(2):228. doi: 10.3390/cells12020228.
8
DNA methylation loci identification for pan-cancer early-stage diagnosis and prognosis using a new distributed parallel partial least squares method.使用一种新的分布式并行偏最小二乘法进行全癌早期诊断和预后的DNA甲基化位点鉴定。
Front Genet. 2022 Oct 19;13:940214. doi: 10.3389/fgene.2022.940214. eCollection 2022.
9
Inhibition of DNAJC12 Inhibited Tumorigenesis of Rectal Cancer via Downregulating HSPA4 Expression.DNAJC12的抑制通过下调HSPA4表达抑制直肠癌的肿瘤发生。
Evid Based Complement Alternat Med. 2022 Sep 21;2022:1027895. doi: 10.1155/2022/1027895. eCollection 2022.
10
Apoptosis-Associated Gene Expression Profiling Is One New Prognosis Risk Predictor of Human Rectal Cancer.凋亡相关基因表达谱分析是预测人直肠癌预后的一个新的风险预测因子。
Dis Markers. 2022 Apr 23;2022:4596810. doi: 10.1155/2022/4596810. eCollection 2022.
新辅助放化疗后直肠癌患者再分期:系统评价。
World J Surg. 2020 Mar;44(3):973-979. doi: 10.1007/s00268-019-05309-z.
4
Advances in the management of rectal cancer.直肠癌治疗进展
Curr Probl Surg. 2019 Nov;56(11):100648. doi: 10.1016/j.cpsurg.2019.100648. Epub 2019 Aug 6.
5
Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines.比较临床指南中的推荐意见揭示直肠癌管理中的灰色地带和证据差距。
Cancer Treat Rev. 2020 Jan;82:101930. doi: 10.1016/j.ctrv.2019.101930. Epub 2019 Nov 11.
6
Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers.代谢基因改变影响 32 种人类癌症的临床侵袭性和药物反应。
Commun Biol. 2019 Nov 14;2:414. doi: 10.1038/s42003-019-0666-1. eCollection 2019.
7
The risk of distant metastases in rectal cancer managed by a watch-and-wait strategy - A systematic review and meta-analysis.观察等待策略治疗直肠癌远处转移的风险:系统评价和荟萃分析。
Radiother Oncol. 2020 Mar;144:1-6. doi: 10.1016/j.radonc.2019.10.009. Epub 2019 Nov 8.
8
MTHFD1L, A Folate Cycle Enzyme, Is Involved in Progression of Colorectal Cancer.MTHFD1L,一种叶酸循环酶,参与结直肠癌的进展。
Transl Oncol. 2019 Nov;12(11):1461-1467. doi: 10.1016/j.tranon.2019.07.011. Epub 2019 Aug 14.
9
Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China.中国江苏省结直肠癌患者手术后生存预后因素的临床病理和流行病学特征。
Cancer Epidemiol. 2019 Oct;62:101565. doi: 10.1016/j.canep.2019.07.004. Epub 2019 Jul 16.
10
Dgat2 reduces hepatocellular carcinoma malignancy via downregulation of cell cycle-related gene expression.DGAT2 通过下调细胞周期相关基因表达降低肝癌恶性程度。
Biomed Pharmacother. 2019 Jul;115:108950. doi: 10.1016/j.biopha.2019.108950. Epub 2019 May 8.